Securing America’s Drug Supply from Communist China Act

Summary

It orders the Health and Human Services Secretary to review any new drug applications from companies owned, controlled, or otherwise tied to China, the Chinese Communist Party, or the People’s Liberation Army, and to deny approval if those ties exist. It also directs Customs to refuse entry of such drugs unless the sponsor can prove it is no longer affiliated or sells the rights to a non‑Chinese entity, with a possible waiver if a shortage would result.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share